Subsequent Anticancer Procedures Following First-Line Lenvatinib (Len): A Post Hoc Analysis From The Phase Iii Reflect Study In Unresectable Hepatocellular Carcinoma (Uhcc)
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要